Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

RSS icon
Department of Justice DOJ

CVS subsidiary Oak Street Health fined $60M for kickback scheme

Oak City Health paid $200 for every Medicare Advantage patient refereed to its clinics for services, the U.S Department of Justice said. 

Study ranks US health system dead last among wealthy nations

Low rankings for accessibility and outcomes earned the country the overall lowest ranking in an analysis of healthcare systems across 10 nations.

Cath lab staff working in an outpatient ambulatory surgical center (ASC) for cardiovascular procedures at a Banner Health ASC in Sun City, Arizona.

Cath lab techs and nurses see new normal with post-COVID pay

In the post-COVID era, wages for permanent RNs are rising, and wages for travelers are decreasing. A new report tracked these trends and more. 

Thumbnail

Companies face 6% spike in insurance premiums, will pass cost onto employees

Without deploying cost-saving measures, the price to provide workers with insurance could rise as much as 9%, a report from Mercer found. 

money gavel court lawsuit legal judge judgement

Private cardiology practice accuses hospital of intimidation, defamation in $15M lawsuit

According to Oregon Heart Center, an independent cardiology practice, Salem Health is attempting to "monopolize cardiology care" in the area. The two providers had previously coexisted for years. 

healthcare providers and payers AI strategy

Providers trail payers in healthcare AI action

If putting an AI plan in place were a team sport, the Payers would be outpacing the Providers quite handily. 

pain pills opioids

Landmark opioid trial in Baltimore set to begin; Johnson & Johnson settles to avoid jury

Six companies have settled with the city for as total of over $402M. Two remaining defendants, McKesson and AmerisourceBergen, will test their luck in court.

Thumbnail

Walgreens pays $107M to resolve fraud accusations brought by DOJ

The company was accused of billing the government for prescriptions patients never received. Walgreens said the oversight was a result of a software error. 

Displaying 193 - 200 of 8453

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.